BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23911286)

  • 1. Identification of PHRF1 as a tumor suppressor that promotes the TGF-β cytostatic program through selective release of TGIF-driven PML inactivation.
    Ettahar A; Ferrigno O; Zhang MZ; Ohnishi M; Ferrand N; Prunier C; Levy L; Bourgeade MF; Bieche I; Romero DG; Colland F; Atfi A
    Cell Rep; 2013 Aug; 4(3):530-41. PubMed ID: 23911286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling.
    Faresse N; Colland F; Ferrand N; Prunier C; Bourgeade MF; Atfi A
    EMBO J; 2008 Jul; 27(13):1804-15. PubMed ID: 18511908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling.
    Seo SR; Ferrand N; Faresse N; Prunier C; Abécassis L; Pessah M; Bourgeade MF; Atfi A
    Mol Cell; 2006 Aug; 23(4):547-59. PubMed ID: 16916642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the PHRF1 Tumor Suppressor Network by PML-RARα Drives Acute Promyelocytic Leukemia Pathogenesis.
    Prunier C; Zhang MZ; Kumar S; Levy L; Ferrigno O; Tzivion G; Atfi A
    Cell Rep; 2015 Feb; 10(6):883-890. PubMed ID: 25683711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCTA: a new player in TGF-beta signaling.
    Liu F
    Sci Signal; 2008 Nov; 1(46):pe49. PubMed ID: 19018012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic PML function in TGF-beta signalling.
    Lin HK; Bergmann S; Pandolfi PP
    Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity.
    Pessah M; Prunier C; Marais J; Ferrand N; Mazars A; Lallemand F; Gauthier JM; Atfi A
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6198-203. PubMed ID: 11371641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF.
    Dai C; Liu Y
    J Am Soc Nephrol; 2004 Jun; 15(6):1402-12. PubMed ID: 15153551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells.
    Hamid R; Brandt SJ
    Mol Oncol; 2009 Dec; 3(5-6):451-63. PubMed ID: 19699159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative interplay of retinoic acid and TGF-β signaling mediated by TG-interacting factor to modulate mouse embryonic palate mesenchymal-cell proliferation.
    Liu X; Zhang H; Gao L; Yin Y; Pan X; Li Z; Li N; Li H; Yu Z
    Birth Defects Res B Dev Reprod Toxicol; 2014 Dec; 101(6):403-9. PubMed ID: 25477235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
    Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
    Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHRF1 promotes genome integrity by modulating non-homologous end-joining.
    Chang CF; Chu PC; Wu PY; Yu MY; Lee JY; Tsai MD; Chang MS
    Cell Death Dis; 2015 Apr; 6(4):e1716. PubMed ID: 25855964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative functional interaction of retinoic acid and TGF-beta signaling mediated by TG-interacting factor during chondrogenesis.
    Zhang H; Li N; Tang Y; Wu W; Zhang Q; Yu Z
    Cell Physiol Biochem; 2009; 23(1-3):157-64. PubMed ID: 19255510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF.
    Lo RS; Wotton D; Massagué J
    EMBO J; 2001 Jan; 20(1-2):128-36. PubMed ID: 11226163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
    Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
    Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.